Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides
- PMID: 20638440
- DOI: 10.1016/j.pneurobio.2010.07.003
Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides
Abstract
The scientific understanding of preproglucagon derived peptides has provided people with type 2 diabetes with two novel classes of glucose lowering agents, the dipeptidyl peptidase IV (DPP-IV) inhibitors and GLP-1 receptor agonists. For the scientists, the novel GLP-1 agonists, and DPP-IV inhibitors have evolved as useful tools to understand the role of the preproglucagon derived peptides in normal physiology and disease. However, the overwhelming interest attracted by GLP-1 analogues as potent incretins has somewhat clouded the efforts to understand the importance of preproglucagon derived peptides in other physiological contexts. In particular, our neurobiological understanding of the preproglucagon expressing neuronal pathways in the central nervous system as well as the degree to which central GLP-1 receptors are targeted by peripherally administered GLP-1 receptor agonists is still fairly limited. The role of GLP-1 as an anorectic neurotransmitter is well recognized, but clarification of the neuronal targets and physiological basis of this response is further warranted, as is the mapping of GLP-1 sensitive neurons involved in a variety of neuroendocrine and behavioral responses. Further recent evidence points to GLP-1 as a central neuropeptide with neuroprotective capabilities potentially mitigating a wide array of neurodegenerative conditions. It is the aim of the present review to summarize our current understanding of preproglucagon derived peptides as neurotransmitters in the central nervous system.
Copyright © 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei.Brain Res. 2007 May 29;1149:118-26. doi: 10.1016/j.brainres.2007.02.043. Epub 2007 Feb 27. Brain Res. 2007. PMID: 17433266
-
Central pre-proglucagon derived peptides: opportunities for treatment of obesity.Curr Pharm Des. 2003;9(17):1373-82. doi: 10.2174/1381612033454775. Curr Pharm Des. 2003. PMID: 12769729 Review.
-
Biologic actions and therapeutic potential of the proglucagon-derived peptides.Nat Clin Pract Endocrinol Metab. 2005 Nov;1(1):22-31. doi: 10.1038/ncpendmet0017. Nat Clin Pract Endocrinol Metab. 2005. PMID: 16929363 Review.
-
The avian proglucagon system.Gen Comp Endocrinol. 2009 Sep 1;163(1-2):39-46. doi: 10.1016/j.ygcen.2008.09.010. Epub 2008 Oct 1. Gen Comp Endocrinol. 2009. PMID: 18938167 Review.
-
Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter.Regul Pept. 2005 Jun 15;128(2):97-107. doi: 10.1016/j.regpep.2004.08.026. Regul Pept. 2005. PMID: 15780429 Review.
Cited by
-
L-carnitine and Ginkgo biloba Supplementation In Vivo Ameliorates HCD-Induced Steatohepatitis and Dyslipidemia by Regulating Hepatic Metabolism.Cells. 2024 Apr 23;13(9):732. doi: 10.3390/cells13090732. Cells. 2024. PMID: 38727268 Free PMC article.
-
Physiological Appetite Regulation and Bariatric Surgery.J Clin Med. 2024 Feb 27;13(5):1347. doi: 10.3390/jcm13051347. J Clin Med. 2024. PMID: 38546831 Free PMC article. Review.
-
Gut-Brain Axis Modulation of Metabolic Disorders: Exploring the Intertwined Neurohumoral Pathways and Therapeutic Prospects.Neurochem Res. 2024 Apr;49(4):847-871. doi: 10.1007/s11064-023-04084-7. Epub 2024 Jan 20. Neurochem Res. 2024. PMID: 38244132 Review.
-
State of art on the mechanisms of laparoscopic sleeve gastrectomy in treating type 2 diabetes mellitus.World J Diabetes. 2023 Jun 15;14(6):632-655. doi: 10.4239/wjd.v14.i6.632. World J Diabetes. 2023. PMID: 37383590 Free PMC article. Review.
-
GLP-1 receptor agonists for the treatment of obesity: Role as a promising approach.Front Endocrinol (Lausanne). 2023 Feb 1;14:1085799. doi: 10.3389/fendo.2023.1085799. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843578 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases